Researchers have launched a new clinical trial that uses a hormone suppresser commonly used to treat men with prostate cancer to help improve clinical outcomes for men infected with COVID-19.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: